Literature summary for 3.4.14.5 extracted from

Herman, G.A.; Stein, P.P.; Thornberry, N.A.; Wagner, J.A.
Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: focus on sitagliptin (2007), Clin. Pharmacol. Ther., 81, 761-767.

Search for more literature for 3.4.14.5

Application

Application	Comment	Organism
medicine	sitagliptin is a selective DPP-4 inhibitor that enhances intact incretin levels and improves 24-h glycemic control in patients with type 2 diabetes	Homo sapiens

Inhibitors

Inhibitors	Comment	Organism	Structure
sitagliptin	sitagliptin is a selective DPP-4 inhibitor that enhances intact incretin levels and improves 24-h glycemic control in patients with type 2 diabetes	Homo sapiens

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	-	-	-

Synonyms

Synonyms	Comment	Organism
dipeptidyl peptidase-4	-	Homo sapiens
DPP-4	-	Homo sapiens

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)